Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’s
‘Altermagnetism’ discovery could deliver ‘thousand-fold increase’ in memory and speed of computing components
Fatty molecules also found in UPFs seen at high levels in colorectal tumours
Unusually hot seas lead to more rain, causing flooding in many parts of the world
Latest findings bring forward possible date and follow dramatic sea ice loss around north pole recorded since 1980s
As our immune systems demonstrate, we need built-in redundancies to function during crisis
Jonathan Watts nimbly dissects the brilliance and flaws of the father of Gaia theory
Research intensifies debate over health risks of mass-produced goods made more palatable for consumers
This is a time for treating people as individuals rather than as members of a tribe
Author recommends breaking ‘siloed’ work practices to spur life sciences sector and improve care
Forecasting the last seven days of life is harder than the final 24 hours; beyond that, things become shakier still
Scientific research into how plastics affect the body is in its early days
As concerns mount about pollutants such as PFAS, the market for remediation is poised for rapid growth
Jay Bhattacharya at the NIH would be the latest ally of Robert F Kennedy Jr to take a role overseeing US healthcare
In windowless labs in Colorado sit the 20 atomic clocks the world sets its watch by. They’re barely keeping up
Effort to understand cellular functions promises to unlock crucial information about personal health
Robert F Kennedy Jr’s appointment is characteristic of Trump’s hostility to expertise
Test was setback for owner Elon Musk, who has become an influential figure in president-elect’s transition team
Pilita Clark, Clive Cookson and John Thornhill select their must-read titles
UK aerospace and engineering group in early talks over commercial opportunities for planned technology
The woes of 23andMe highlight consumer concern over privacy issues
Sharp rise in cases over 30 years compounded by millions of people lacking access to medication, Lancet study finds
People prone to breast cancer and diabetes among beneficiaries of early testing
Companies are racing to build machines that are more intelligent and more like us
Give us your recommendations and pick up tips for your own reading list
